American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain.

ABSTRACT:

Background

The management of acute and chronic pain for individuals living with sickle cell disease (SCD) is a clinical challenge. This reflects the paucity of clinical SCD pain research and limited understanding of the complex biological differences between acute and chronic pain. These issues collectively create barriers to effective, targeted interventions. Optimal pain management requires interdisciplinary care.

Objective

These evidence-based guidelines developed by the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in pain management decisions for children and adults with SCD.

Methods

ASH formed a multidisciplinary panel, including 2 patient representatives, that was thoroughly vetted to mini

SUBMITTER: Brandow AM 

PROVIDER: S-EPMC7322963 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature